HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

DoJ's COVID-19 Fraud Enforcement Gets A Director

Executive Summary

Associate Deputy Attorney General Kevin Chambers oversees DoJ’s enforcement and prosecution of COVID-19 criminal and civil fraud.

You may also be interested in...



Consumers Vulnerable To False Supplement Claims, Plus Products For ‘Gym Rats’ Get US DoJ Attention

DoJ criminal prosecutions in supplement sector have focused on undisclosed steroids targeted for consumers typically aware the products contain more than labels indicate. But weighing consumers’ vulnerability to false claims also factors in federal prosecutors’ decisions on seeking criminal charges in consumer health products sector.

Califf Pledges To Counter Misinformation As He Returns To US FDA Helm

FDA commissioner's commitment to counter misinformation also appears to include pledge to ensure agency is driven by science-based decisions, not politics.

Children's Use Of New Earth Healing's Colloidal Silver Eye Drops, Nasal Sprays Concerns US FDA

Children, a vulnerable population, are particularly at risk of "unpredictable and unintended consequences" from untested drug products, FDA warns colloidal silver marketer.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152295

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel